Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis

摘要

Background: Understanding the true prevalence of lymphangioleiomyomatosis (LAM) is important in estimating disease burden and targeting specific interventions. As with all rare diseases, obtaining reliable epidemiological data is difficult and requires innovative approaches.